MARSHALL & POPP, LLC

Lobbying for CSL BEHRING · Biopharmaceutical manufacturer.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $40,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Pharmacy

Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to regulation of pharmaceuticals. H.R.1476-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act).

Trade (domestic/foreign)

Issues related to tariff and trade policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.